Clinical evaluation of a laboratory-developed test using clone E1L3N for the detection of PD-L1 expression status in non-small cell lung cancer.
Hanyan XuXidan DongHanxin ZhaoTongtong HouChengshui ChenGuorong ChenJunru YeYuping LiPublished in: Journal of clinical laboratory analysis (2021)
E1L3N can be used as a reliable alternative antibody clone to evaluate PD-L1 expression status for NSCLC patients.